SPIB and infection: Mycobacterium tuberculosis translocates across M cells to initiate infection in vivo, but the genetic inhibition of Spib or IK22-5 (RANKL monoclonal antibody) treatment prevents M. tuberculosis dissemination, leading to improved survival of mice [19].